We came across a bullish thesis on ResMed Inc. on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.'s share was trading at $273.01 as of October 13th. RMD’s trailing and forward P/E were 29.09 and 25.91 respectively according to Yahoo Finance. Meta Stock: $750 Target Stays as Analysts Expect AI Gaps to Close Billion Photos/Shutterstock.com ResMed (RMD) has quietly established itself as one of the most durable medtech franchises over the past five years, ...